Table 1. Cardiac function of women with breast cancer, treated with DOX-based chemotherapy.
Number of patients | Average LVEF (%) at baseline* | Average LVEF (%) at completion of chemotherapy* | |
---|---|---|---|
Patients with abnormal LVEF (%) | 8 | 69.875 ± 5.436 | 57.875 ± 3.833 |
18–47 years | 2 | 68.5 ± 2.121 | 57.5 ± 0.707 |
48–55 years | 2 | 64.0 ± 0 | 54.0 ± 0 |
>56 years | 4 | 73.5 ± 5.066 | 60.0 ± 4.242 |
Patients with normal LVEF (%) | 25 | 61.583 ± 5.523 | 61.833 ± 6.919 |
18–47 years | 9 | 60.888 ± 6.050 | 62.222 ± 9.162 |
48–55 years | 9 | 60.888 ± 5.065 | 59.777 ± 5.118 |
>56 years | 7 | 63.142 ± 5.080 | 57.714 ± 6.499 |
LVEF, left ventricle ejection fraction
*Mean ± SD